Menard Chrystal

Avg. Two Year Performance

No purchase track record
5% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(5%)(5%)(10%)5%5%
Sale Success Rate1 of 41 of 41 of 41 of 41 of 4
Drugs » Biotechnology

Chief Legal Officer:

Holdings: 48.59K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--